One page, thousands of outlets. See who else covered it.
(RTTNews) - Sight Sciences, Inc. (SGHT), an eyecare technology company, on Wednesday said the U.S. Food and Drug Administration has expanded the indications for its TearCare System, making it the first treatment for meibomian gland dysfunction or MGD specifically cleared to impro
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Once the State Medical Council grants registration and the Ethics and Medical Registration Board allots the UID, a doctor will not require fresh registration or a separate licence to practise in…
Cancer "vaccine" successfully slowed melanoma, dissecting Chinese trial strategy in wake of deaths, and more health news from Morning Rounds
The mRNA-based vaccine combined with Keytruda reduced melanoma recurrence in more than 1,100 patients whose cancer had been surgically removed
Unconventional business leadership lessons learned the hard way
The KwaZulu-Natal Department of Health has condemned a viral video showing a nurse physically assaulting a patient at King Dinuzulu Hospital, prompting calls for disciplinary action and criminal…
Chronic wounds affect about 450,000 Australians every year, requiring ongoing at-home monitoring, care and treatment to prevent infection.
